Date: April 16th, 2021

Location: TC REMEDIA, Romania

Participants:

Farmaceutica REMEDIA Valentin-Norbert TARUS President of the Board of Administrators / General Director
  Adrian-Marcel PARVU Member of the Board of Administrators
  Zoe CHIRITA Investor Relations Director
  Elena CODREAN Member of the Board of Administrators / Financial Director
  Rixandra TICA Administrator FR & DL
  Florin CADIA Investor Relations Specialist
     
Financial analysts/Guests Ovidiu SERDEAN IFB Finwest
  Daniela ALDESCU ARIR
     
Journalists Andrei IACOMI Bursa
     
Shareholders Emil Dragos IONESCU  
  Ionel Marius MARIAN  
     

After the opening of the conference and the presentation of the participants, Mr. Valentin – Norbert TARUS, President of the Board opens the discussions through a dialogue with Mr. Iacomi from Bursa, about the performance of pharmaceutical companies, about the financial returns of these companies and the expectations of investors. Mr. Iacomi states that the main companies that have given high dividends are those in the banking and energy field, those in the pharmaceutical field have low returns or do not give dividends and the perspective is of declining returns.

Mr. Ionescu, shareholder – states that investors’ interests are related to dividends, but the development perspective of companies is also pursued, there are large companies that do not pay dividends but develop and pay dividends later. He states that last year’s transaction was beneficial for investors, led to a greater presence of the company in the press, forums, discussions and then to an increase in the share price, a pleasant surprise.

Mr. Valentin – Norbert TARUS, President of the Board – answers the question of Mr. Ionescu about the intention to negotiate other sales, or if there are discussions for the sale of the distribution. The pharmaceutical distribution market is dominated by large companies (Farmexim, Farmexpert), and for medium distributors, such as FR&DL, which has a market share of 2.5-3%, the perspective of attracting investment funds, mergers or opening of dialogues with customers or competitors must exist.

Mr. Valentin – Norbert TARUS, President of the Board – reminds the participants that Farmaceutica REMEDIA has paid dividends every year and aims to pay more than the return offered by the banks every year.

Mr. Ionescu, shareholder, states that indeed REMEDIA had a correct dividend policy, of over 50% of the profit.

Ms. Elena Codrean, Financial Director / Board Member – presents some key aspects related to the financial results of 2020: turnover, income, expenses, profit and distribution to dividends.

Ovidiu Serdean, IFB Finwest – completes, related to the return and dividends of pharma companies, that at Biofarm is 3,3%.

Mr. Andrei Iacomi, Bursa – wants to know what the estimated increase in sales revenue by 15% is based on, in BVC for 2021.

Mr. Valentin – Norbert TARUS, President of the Board – states that any change in the market offers new opportunities, in the current pandemic context REMEDIA has reoriented and directly imports antigen tests from China, intuiting that to end the pandemic, in addition to vaccination, massive testing is necessary. REMEDIA wants to open new business lines in the field of process automation and digitization, for this purpose it has partnered with BD Rowa, a manufacturer of robots for pharmacies and will develop a line of promotion and installation of these solutions in pharmacies.

Regarding the investments in the logistics centers in Deva and Bucharest, Mr. Valentin – Norbert TARUS states that the investments are within the proposed parameters.

Mr. Ovidiu Serdean, IFB Finwest – asks if the remaining pharmacies can be a potential sales target or if they stay in the company.

Mr. Valentin – Norbert TARUS, President of the Board – states that REMEDIA, by selling the pharmacies to HelpNet, has left this market and does not intend to re-enter, and the remaining pharmacies may be a sales target.

Mr. Marian, shareholder – wants that Farmaceutica REMEDIA to be more active, more present in the media and on the stock market.

Mr. Valentin – Norbert TARUS, President of the Board – states that Farmaceutica REMEDIA is developing a national platform (www.test-covid19.ro) to join doctors and nurses to provide testing services for the population, the platform that will be launched soon.

Mr. Valentin – Norbert TARUS, President of the Board states that Farmaceutica REMEDIA also delivers Covid tests to other pharmacy chains and the project for testing the population in pharmacies mentioned by Mr. Ionescu, will be beneficial.

Daniela Aldescu, ARIR – appreciates the efforts and openness of the management of REMEDIA, which is in the top of the companies in the Vektor ranking and the Vektor index for 2020 is increasing compared to the previous year. Changes have been made and as much information as possible has been provided to investors, implementing best practices.

Ms. Zoe Chirita, IR Director – thanks ARIR for support and guidance and Mr. Serdean for his involvement in organizing the events organized by Farmaceutica REMEDIA.

Ms. Zoe Chirita, IR Director – thanks ARIR for support and guidance and Mr. Serdean for his involvement in organizing the events organized by Farmaceutica REMEDIA.

Download presentation

No Comment

Comments are closed.